Compare AJANTA PHARMA with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA NATCO PHARMA AJANTA PHARMA/
NATCO PHARMA
 
P/E (TTM) x 27.7 34.0 81.6% View Chart
P/BV x 6.8 4.8 141.8% View Chart
Dividend Yield % 0.5 0.7 73.6%  

Financials

 AJANTA PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-19
NATCO PHARMA
Mar-19
AJANTA PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,422849 167.5%   
Low Rs898557 161.1%   
Sales per share (Unadj.) Rs233.5573.8 40.7%  
Earnings per share (Unadj.) Rs44.0176.0 25.0%  
Cash flow per share (Unadj.) Rs52.2198.2 26.3%  
Dividends per share (Unadj.) Rs9.006.25 144.0%  
Dividend yield (eoy) %0.80.9 87.3%  
Book value per share (Unadj.) Rs255.1842.7 30.3%  
Shares outstanding (eoy) m88.0236.50 241.2%   
Bonus/Rights/Conversions BBBB-  
Price / Sales ratio x5.01.2 405.4%   
Avg P/E ratio x26.44.0 660.4%  
P/CF ratio (eoy) x22.23.5 626.9%  
Price / Book Value ratio x4.50.8 545.0%  
Dividend payout %20.53.6 576.5%   
Avg Mkt Cap Rs m102,08125,660 397.8%   
No. of employees `0006.85.0 137.2%   
Total wages/salary Rs m4,3073,559 121.0%   
Avg. sales/employee Rs Th3,022.64,225.3 71.5%   
Avg. wages/employee Rs Th633.4718.0 88.2%   
Avg. net profit/employee Rs Th569.11,295.9 43.9%   
INCOME DATA
Net Sales Rs m20,55420,945 98.1%  
Other income Rs m2111,302 16.2%   
Total revenues Rs m20,76522,247 93.3%   
Gross profit Rs m5,6647,948 71.3%  
Depreciation Rs m721810 89.0%   
Interest Rs m12193 6.0%   
Profit before tax Rs m5,1438,247 62.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,2731,823 69.8%   
Profit after tax Rs m3,8706,424 60.2%  
Gross profit margin %27.637.9 72.6%  
Effective tax rate %24.822.1 112.0%   
Net profit margin %18.830.7 61.4%  
BALANCE SHEET DATA
Current assets Rs m11,81223,472 50.3%   
Current liabilities Rs m3,7767,287 51.8%   
Net working cap to sales %39.177.3 50.6%  
Current ratio x3.13.2 97.1%  
Inventory Days Days7792 83.9%  
Debtors Days Days8288 92.5%  
Net fixed assets Rs m14,39818,648 77.2%   
Share capital Rs m175365 48.1%   
"Free" reserves Rs m22,27734,525 64.5%   
Net worth Rs m22,45230,760 73.0%   
Long term debt Rs m70-   
Total assets Rs m26,96243,031 62.7%  
Interest coverage x444.343.7 1,016.1%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.5 156.6%   
Return on assets %14.415.4 93.6%  
Return on equity %17.220.9 82.5%  
Return on capital %23.027.4 83.6%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m10,68211,536 92.6%   
Fx outflow Rs m2,1022,939 71.5%   
Net fx Rs m8,5808,597 99.8%   
CASH FLOW
From Operations Rs m3,7486,688 56.0%  
From Investments Rs m-2,228-6,122 36.4%  
From Financial Activity Rs m-1,475-509 289.7%  
Net Cashflow Rs m4566 68.5%  

Share Holding

Indian Promoters % 73.8 52.0 141.8%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 1.6 7.8 19.8%  
FIIs % 7.6 16.6 45.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.0 26.0 65.4%  
Shareholders   20,968 25,395 82.6%  
Pledged promoter(s) holding % 4.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare AJANTA PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 531 Points; Reliance Industries & IndusInd Bank Fall 5%(Closing)

Indian share markets witnessed huge selling pressure today and failed to hold on to their opening gains as profit booking and weakness across all sectors erased gains.

Related Views on News

AJANTA PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 46.3% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, AJANTA PHARMA has posted a net profit of Rs 2 bn (up 46.3% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 28.9% (Quarterly Result Update)

Aug 24, 2020 | Updated on Aug 24, 2020

For the quarter ended June 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 28.9% YoY). Sales on the other hand came in at Rs 7 bn (up 9.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 45.3% (Quarterly Result Update)

May 21, 2020 | Updated on May 21, 2020

For the quarter ended March 2020, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 45.3% YoY). Sales on the other hand came in at Rs 7 bn (up 32.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 60.8% (Quarterly Result Update)

Feb 6, 2020 | Updated on Feb 6, 2020

For the quarter ended December 2019, AJANTA PHARMA has posted a net profit of Rs 1 bn (up 60.8% YoY). Sales on the other hand came in at Rs 7 bn (up 34.2% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

Time to Book Profits in Pharma Stocks(Fast Profits Daily)

Jan 15, 2021

In this video, I'll show you why it might be the right time to take money of the table in pharma stocks.

Smallcap Stocks: Your Best Bet for 2021 and Beyond(Profit Hunter)

Jan 15, 2021

The pandemic failed to thwart Richa's investing success formula for 2020.

One Chart to See Before You Sell(Fast Profits Daily)

Jan 22, 2021

In this video, I'll show you a crucial chart that you need to check before you decide to sell any stock or index.

Invest in the Multibaggers of 2021 and Beyond(Profit Hunter)

Jan 21, 2021

Our ace stock picker is ready to capitalise on a big growth opportunity.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

AJANTA PHARMA SHARE PRICE


Jan 25, 2021 (Close)

TRACK AJANTA PHARMA

  • Track your investment in AJANTA PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AJANTA PHARMA 5-YR ANALYSIS

COMPARE AJANTA PHARMA WITH

MARKET STATS